POSTUPCI ZA LIJEČENJE OSTEOGENESIS IMPERFECTA

• 收藏
• 分享

专利权人:

Baylor College Of Medicine;Genzyme Corporation

发明人:

Lee, Brendan,Sampath, Kuber

申请号：

HRP20192277

公开号：

HRP20192277T1

申请日:

2019.12.17

申请国别(地区):

HR

年份:

2020

代理人:

摘要：

The present invention provides methods for treating and improving the symptoms of osteogenesis imperfecta (OI) in a subject by administering to the subject a therapeutically effective amount of a binding agent that binds to transforming growth factor beta (TGF²).

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/